Is it possible to lengthen telomeres? What science really knows

Yes, telomeres can be lengthened at the cellular level, and there are indeed cases in humans where their measured length has increased. However, this doesn't yet mean that a healthy person can safely "lengthen telomeres," rejuvenate the body, and prolong life. Telomerase, an enzyme capable of adding repeating sections of DNA to the ends of chromosomes, biologically solves precisely this problem. Some studies of physical activity, comprehensive lifestyle changes, the drug danazol for rare telomere disorders, and the supplement TA-65 have observed preservation or increase in telomere length. However, the results are mixed, and most importantly, an increase in laboratory parameters has not yet proven an increase in healthy lifespan.

As of September 2026, there is no approved anti-aging therapy for which artificial telomere lengthening in healthy individuals has been shown to reduce disease, preserve function, or prolong life. A major 2025 review of aging biomarkers explicitly states that telomerase gene therapy has no proven therapeutic effect against aging in humans. And an August 11, 2026, Nature Medicine editorial highlights a broader problem with the modern longevity industry: the molecular effects of many interventions significantly outpace the evidence for their clinical benefit. [1]

There's another reason why the goal of "making telomeres as long as possible" is itself questionable. Telomeres that are too short can limit tissue regeneration, but excessively long telomeres are not necessarily beneficial either: genetic studies link inherited long telomere length to an increased risk of a range of tumors. In 2026, a group at Johns Hopkins University further described a hereditary long telomere syndrome associated with an increased susceptibility to lymphoid malignancies. Therefore, normal telomere biology is more akin to maintaining an optimal range than competing for maximum length. [2]

For a generally healthy person today, it's wiser not to try to directly activate telomerase, but to instead engage in activities proven to improve health independently of telomeres: regular exercise, not smoking, maintaining adequate sleep, managing body weight and cardiovascular risk factors, and eating a balanced diet. Some of these activities are indeed associated with longer telomeres or slower telomere shortening, but the telomere effect should be considered a possible additional biological consequence, not the primary goal of treatment or lifestyle interventions. [3]

What are telomeres and why are they needed?

Telomeres are repetitive DNA sequences at the ends of chromosomes. They can be thought of as protective caps that help cells distinguish the normal end of a chromosome from damaged DNA and prevent unwanted chromosome fusions. The National Human Genome Research Institute updated its definition of telomeres on September 3, 2026, emphasizing their protective function. [4]

In many somatic cells, telomeres shorten slightly with each division. This is due, in part, to the way the ends of linear DNA are copied. When certain telomeres become critically short and lose their normal protective structure, the cell may cease dividing, enter a state of cellular senescence, or die. [5]

But the body is not completely defenseless against this process. There is an enzyme called telomerase, which can complete telomeric repeat sequences. Its activity is particularly important in cells that need to divide repeatedly, including some stem, germ, and immune cells. The US National Cancer Institute defines telomerase as an enzyme that adds DNA to telomeres, thereby helping maintain the cell's ability to continue to exist and divide. [6]

Therefore, the answer to the question of whether telomere lengthening is possible in principle is unequivocal: biologically, yes. The debate begins at the next level: whether this process in the human body can be controlled with sufficient precision, safely, and in a way that will yield real health benefits.

Telomere is not a simple "life counter"

A popular analogy imagines the telomere as a wick: the shorter it is, the less life remains. At the cellular level, shortening does limit the ability of some cells to repeatedly divide, but for the whole human being, this model is too simplistic.

Telomere length is highly variable. It is influenced by heredity, age, tissue type, immune system characteristics, diseases, and environmental exposures. An analysis of more than 20 human tissues from 952 people revealed significant differences between tissues: within the same age group, telomeres in blood, muscle, skin, reproductive tissue, and other organs can have different lengths. [7]

Moreover, telomere lengths across different tissues in the same person correlate, on average. A meta-analysis of 55 studies, covering over 4,300 people and 102 tissue types, found a moderate intertissue correlation, but its magnitude depended on the tissue used and the measurement method. Therefore, leukocyte telomere analysis does provide biological information, but it is not a direct measurement of telomeres in the brain, heart, or any other specific organ. [8]

This is related to the fundamental error of the commercial formulation "your telomeres correspond to the age of 43." A review of the clinical significance of telomere length concludes that this indicator alone allows only a very approximate assessment of biological aging and is not reliable enough as an individual predictor of age-related diseases and mortality. [9]

Can telomere length increase on its own?

Yes, repeated measurements do show an increase in average telomere length in some people. This isn't necessarily a laboratory error: biological dynamics exist, telomerase is active in some cells, and the composition of blood cell populations can change.

However, a serious methodological problem arises here. Telomere changes over one or two years are relatively small, while the error of some popular measurement methods can be comparable to the magnitude of the change itself. A study of repeated measurements showed that quantitative polymerase chain reaction correlated well with the more direct method when assessing individuals at a single point in time, but was significantly less effective at determining telomere length change in an individual over time. [10]

An additional complication lies in the composition of blood. Leukocytes are not a single cell population: different types of immune cells have different telomere characteristics, and their proportions can change with infection, inflammation, treatment, and age. Therefore, changes in the average blood count sometimes reflect not only actual telomere lengthening within specific cells, but also changes in the composition of the measured cellular mixture. [11]

Therefore, a commercial test's message that "your telomeres have grown by 400 base pairs in a year" cannot be automatically interpreted as proof that the body has become younger by a certain number of years.

Why too-short telomeres can actually be a problem

There are rare diseases in which the problem of short telomeres has very real clinical significance. Hereditary disorders of telomerase or other telomere maintenance systems can lead to so-called telomere syndromes. These syndromes are associated, for example, with bone marrow failure, aplastic anemia, pulmonary fibrosis, liver disease, and certain types of cancer. [12]

In such situations, telomeres are no longer an abstract indicator of "biological age," but rather part of the underlying disease mechanism. It is in these patients that methods for restoring telomere function are being studied, including androgens and future short-term telomerase activation methods.

This is fundamentally different from the situation of a healthy 55-year-old who wants to "rejuvenate their cells." Treatment for a severe disease caused by abnormally short telomeres does not prove the need to lengthen normal telomeres in the healthy population.

Why the longest telomeres aren't ideal either

The logic of "short is bad, so long is always good" doesn't work. Cellular organisms constantly balance between regeneration and protection from uncontrolled division.

Most normal somatic cells have a limited ability to maintain telomeres. Malignant cells, on the other hand, must overcome this limitation to continue dividing virtually indefinitely. Therefore, many tumors reactivate telomerase; the US National Cancer Institute notes that cancer cells typically have higher telomerase activity than most normal cells. [13]

A recent review in Physiological Reviews indicates that telomerase reactivation is observed in approximately 85% of tumors. This does not mean that a short-term increase in telomerase alone causes cancer: numerous other changes are required for malignant transformation. However, the ability to preserve telomeres may give an already damaged cell additional time and the opportunity to continue reproducing. Therefore, widespread, uncontrolled telomerase activation requires particularly rigorous safety testing. [14]

Genetic data support this caution. Mendelian randomization shows that hereditarily longer telomeres are associated with a reduced risk of some non-cancerous diseases, but also with an increased risk of a number of tumors, including glioma, lung adenocarcinoma, melanoma, and some other cancers. This is one of the most obvious examples of biological trade-off: the same trait can have both advantages and disadvantages. [15]

Particularly revealing is the discovery of hereditary long telomere syndrome, associated with abnormalities in the POT1 gene. Research by Mary Armanios's group shows that excessively long cellular lifespan in this genetic condition is accompanied by a predisposition to tumors, including diseases of the lymphoid system. [16]

Does exercise lengthen telomeres?

Physical activity may have some effect on telomere dynamics, but the evidence is significantly weaker than the evidence for the overall health benefits of exercise.

In a meta-analysis of randomized and controlled trials in healthy adults published in 2023, the overall effect of exercise on telomere length was not statistically significant. A positive effect was found in the high-intensity interval training subgroup, but more than half of the studies were at high risk of bias, and the certainty of most results was low or very low. [17]

A larger 2025 review and meta-analysis, which combined the results of 22 primary studies, found a small to moderate positive effect of physical activity on telomere length. The effect varied depending on the duration and type of exercise, and the authors again emphasized the need for more high-quality, standardized studies. [18]

Another 2025 meta-analysis of randomized trials found evidence of preserved telomere length and increased telomerase activity after exercise, but separate conclusions about the specific type of training were based on a limited number of studies.[19]

Therefore, the correct practical conclusion is not "do interval training to lengthen telomeres," but rather exercise regularly because physical activity has been proven to be beneficial for cardiovascular health, muscle mass, metabolism, and functional health; possible slower telomere aging may be one of the accompanying biological effects.

Can diet lengthen telomeres?

There's no definitive "telomere diet" yet. Studies of the Mediterranean diet often find that people who adhere to it better have slightly longer telomeres. But most of the initial data are observational: people on such a diet may simultaneously be more active, smoke less, have a different body weight, and differ in a host of social and health factors. [20]

A 2022 meta-analysis of complex interventions involving nearly 3,000 people found that a combination of physical activity and dietary changes could be associated with preservation or slight increase in white blood cell telomere length. However, programs varied widely, and telomere length remained an intermediate biomarker rather than a clinical outcome. [21]

A systematic review of randomized nutrition trials published in 2025 found positive signals for individual interventions, including vitamin D, selenium with coenzyme Q10, and certain foods, but the overall picture was highly heterogeneous. The studies were small, used different methods for measuring telomeres, and had varying risks of bias. Therefore, the authors were unable to formulate a universal dietary regimen proven to lengthen telomeres and improve health. [22]

In practice, dietary improvements should be made for their proven effects on cardiovascular risk, diabetes, body weight, and overall health, rather than for the sake of trying to achieve a specific number of telomere base pairs.

Sleep and Telomeres

Poor sleep quality is associated with shorter telomeres, but causality has not yet been established. A large 2025 systematic review and meta-analysis examined data from over 400,000 participants. Some indicators of poor sleep quality and frequent night awakenings were statistically associated with greater telomere attrition. [23]

However, this association doesn't answer the question of causation. Poor sleep can influence inflammation and stress responses, but it's also more common in people with illnesses, obesity, depression, and other conditions that may themselves be associated with telomere length.

Therefore, there's no basis for promising that restoring sleep will "lengthen telomeres." However, insomnia, sleep apnea, and other disorders should still be treated for their own medical reasons.

Smoking and telomere aging

For smoking, the association appears fairly consistent. A systematic review of 84 studies found shorter telomeres in ever-smokers compared to never-smokers, and shorter telomeres in current smokers than in former smokers. A link with cumulative smoking history was also observed. [24]

However, even here, it's impossible to claim that quitting smoking will guarantee "telomere growth." The main reason to quit smoking is far more compelling: it significantly increases the risk of cancer, cardiovascular, and respiratory diseases, independent of telomeres.

Does stress really shorten telomeres?

The link exists, but it is often exaggerated. A meta-analysis of studies on perceived psychological stress found a statistically significant but very small association between greater stress and shorter telomere length. The authors specifically noted the possibility of publication bias, which could have inflated the magnitude of the result. [25]

Therefore, popular assertions like "one year of stress ages telomeres by ten years" lack a reliable, universal basis. Chronic, severe stress undoubtedly has numerous physiological consequences and deserves attention, but telomere measurements don't allow us to translate psychological stress into a precise number of years of life lost.

Can TA-65 lengthen telomeres?

TA-65 is one of the best-known commercial products marketed as a telomerase activator. It is derived from compounds related to the astragalus plant. Unlike many other "telomere" supplements, it actually has several human studies.

A 2016 randomized, double-blind, placebo-controlled study included 117 relatively healthy individuals aged 53–87 years with cytomegalovirus infection. The group receiving a lower dose of TA-65 showed an increase in average telomere length over a year, while it decreased in the placebo group. However, the higher dose did not provide a significant benefit. Furthermore, some of the authors were employees or consultants for the manufacturer, and the study primarily assessed a biomarker rather than healthy life expectancy. [26]

A 2025 systematic review and meta-analysis combined eight randomized trials with approximately 750 participants. On average, supplementation was associated with telomere lengthening, but this was not accompanied by a significant improvement in measures of physical frailty or inflammation. The authors also found larger effects in industry-funded studies and noted that long-term cancer risk remains unknown. [27]

This is a very significant result: changing a biomarker and improving a person are not the same thing. There are no studies yet showing that TA-65 reduces disability, cardiovascular events, dementia, cancer, or mortality, or increases life expectancy in healthy people.

Therefore, TA-65 cannot be considered a proven anti-aging therapy. And even more so, one cannot assume that "if a small dose alters telomeres, then a larger dose will produce greater rejuvenation"—even the initial study did not demonstrate such a relationship. [28]

Are astragalus and cycloastragenol the same thing?

No. The generic herbal preparation of astragalus and the standardized compound TA-65 are not interchangeable. The mere presence of the original herb in a supplement does not mean that the product contains the same molecule, in the same concentration, and with the same bioavailability as the clinically studied product.

Therefore, it is impossible to accurately generalize the TA-65 results to any astragalus tea, extract, or capsule marketed as a "telomerase activator." Studies of the chemistry of cycloastragenol confirm its ability to interact with telomerase mechanisms in experimental systems, but this does not equate to the proven clinical benefits of common herbal supplements. [29]

Danazol shows how complex this topic is

Danazol, a synthetic androgen, is a particularly interesting example because it actually lengthened telomeres in people with abnormally short telomeres.

A small phase I/II study in 2016 involved patients with telomere disorders. After 24 months, most of the participants available for analysis showed an increase in telomere length; some patients also experienced improvements in their hematopoietic parameters. However, the treatment was accompanied by, among other things, elevated liver enzymes and muscle cramps. [30]

This is sometimes used as evidence that androgens can "rejuvenate telomeres." However, more recent data have shown how risky this conclusion is.

In the randomized TELO-SCOPE trial in patients with pulmonary fibrosis and short telomeres, danazol did not slow telomere shortening compared with placebo, and the study was terminated due to futility. Liver enzyme abnormalities were significantly more common with danazol.[31]

Therefore, danazol is not a treatment for lengthening telomeres in healthy individuals. Even in conditions directly related to short telomeres, its effectiveness depends on the specific clinical situation.

There is no medical basis for using danazol, testosterone, or other androgens on your own to “lengthen telomeres.”

Can telomerase be activated by gene therapy?

In experimental models, yes. Researchers have introduced the gene for the catalytic portion of telomerase into cells and animals, achieving telomere lengthening and improvement in certain disease characteristics. This approach is being particularly actively studied in pulmonary fibrosis, where abnormally short telomeres can directly impair the restoration of alveolar epithelium. [32]

In 2025, another promising study emerged: researchers delivered modified messenger ribonucleic acid encoding human telomerase to lung cells and lung tissue samples from patients with terminal fibrosis. In the laboratory, telomerase was activated, telomeres lengthened, and some markers of damage, cellular aging, and fibrosis were reduced. However, this was in cells and isolated human tissue, not in patients undergoing treatment. [33]

In 2026, the Spanish company Telomere Therapeutics is still conducting a preclinical safety program for telomerase gene therapy ahead of a proposed first-in-human trial for idiopathic pulmonary fibrosis. This means that even the treatment for this specific disease is still in the pre-clinical stage. [34]

Moreover, there is no clinically approved gene therapy designed to systemically rejuvenate a healthy body by lengthening telomeres. A recent review in Physiological Reviews explicitly warns against commercial offers of such methods in jurisdictions with inadequate regulation. [35]

Why temporary telomerase activation is more interesting than permanent

If telomerase therapy is ever safely implemented, one of the key issues will be controlling the duration of its action. Continuous activation of the enzyme in all cells is theoretically much riskier than short-term, targeted activation in specific damaged tissue.

This is why new approaches use, for example, modified messenger ribonucleic acid: this molecule temporarily promotes telomerase production and then degrades. Researchers hope to achieve a limited boost in regeneration without permanently altering the cell. However, for now, this is primarily experimental logic, not a proven human therapy. [36]

A much more difficult problem to solve is determining which cells require telomere lengthening, by how much, and for how long. Normal lengths vary within an organ and across different cell populations, so a systemic command to "make all telomeres longer" is biologically too crude.

Why Telomere Lengthening Doesn't Equal Rejuvenation

Aging is a multifaceted process. Even if telomeres are perfectly restored, DNA damage outside the telomeres, epigenetic changes, mitochondrial dysfunction, protein regulation disorders, chronic inflammation, senescent cells, altered intercellular communication, and other processes remain.

Telomere shortening is therefore considered one mechanism of aging, not the sole cause. The latest debate in gerontology is increasingly shifting from attempts to change a single laboratory parameter to testing whether an intervention improves actual physical functioning, disease incidence, and healthy lifespan. In August 2026, the editors of Nature Medicine specifically called for a reduction in the level of hype surrounding rejuvenation interventions until reliable clinical evidence emerges. [37]

This is clearly illustrated by the example of TA-65: the telomere index changed in the meta-analysis, but functional indicators of aging did not improve significantly. [38]

Therefore, the scientifically significant question is not "have telomeres lengthened?" but "have people, as a result, begun to live longer without disease or disability?" There is no positive answer to this question for healthy people yet.

Is it possible to measure telomeres and find out if they need to be lengthened?

For most healthy people, such testing is not a necessary part of a preventive health checkup. Commercial testing can provide interesting research information, but it does not determine how many years a person has left to live or whether they require any treatment.

Measurement methods also vary. Quantitative polymerase chain reaction is convenient for large-scale studies, but has limitations when tracking small changes in a single individual. More sophisticated hybridization methods can provide a more accurate absolute estimate and distribution of telomere lengths, but they are not universally available. [39]

In clinical medicine, telomere measurement is indeed used when telomere-related disease is suspected. For example, the American Thoracic Society, in a 2025 document, notes that flow fluorescence hybridization remains the standard clinical method for such situations, but routine testing of all patients is not recommended due to cost, limited availability, and lack of practical value in most people. [40]

Combinations such as familial pulmonary fibrosis, unexplained low blood cell counts, cirrhosis of unknown origin, premature graying, and a family history of diseases characteristic of telomere syndromes may warrant specialized evaluation. In such situations, testing should be interpreted by a specialist in conjunction with clinical and genetic data. [41]

Why two commercial tests may show different results

Telomere measurements are sensitive to the method, laboratory variability, sample type, and cellular composition. If the difference between two results is small, it may be comparable to the analytical error.

Particular caution should be exercised when comparing analyses performed by different laboratories or using different methods. In studies of telomere length changes, quantitative polymerase chain reaction demonstrated significantly poorer agreement with a more direct method than in single-person comparisons. [42]

Therefore, the result “telomeres lengthened by 7%” only makes sense after answering several questions: what method was used to measure this, was the same laboratory used, what is the reproducibility of the method, and how much does the change exceed its technical error.

What can actually be done today?

If the goal is health and longevity, the most sensible strategy, paradoxically, is to stop making telomeres the primary goal.

Action	What is known about telomeres?	What is known about health
Regular physical activity	Possible preservation or slight increase in telomere length; study results are mixed	The benefits for cardiovascular, metabolic and functional health are well established.
Quitting smoking	Smokers have shorter telomeres on average.	Significantly reduces many proven disease risks
A complete diet	Certain healthy eating patterns are associated with longer telomeres.	Benefit is determined primarily by overall dietary quality and cardiovascular risk.
Normalization of sleep	Poor sleep linked to greater telomere attrition	Sleep is important for many physiological functions independent of telomeres.
Dealing with stress	The association with telomeres is small and mostly observational.	May improve mental health and quality of life
TA-65	There is evidence of possible telomere lengthening	Clinical rejuvenation and life extension have not been proven.
Danazol	May affect telomeres in some telomere diseases; data vary by disease	It is not intended for rejuvenation of healthy people and has side effects.
Telomerase gene therapy	Capable of lengthening telomeres experimentally	There is no clinical anti-aging efficacy in humans.

This table illustrates the central paradox of telomere research. For treatments that significantly improve health, the telomere effect is usually secondary and not fully defined. And for treatments that most directly interfere with telomere biology, the clinical benefits and long-term safety are still insufficiently proven.

What you shouldn't do to lengthen telomeres

You shouldn't self-administer androgens, hormonal agents, or medications based on small studies of telomere disorders. Danazol was used in a very specific group of patients and carries significant risks, including liver dysfunction. A later controlled study in pulmonary fibrosis failed to confirm the expected telomere effect at all. [43]

An expensive supplement should not be considered a proven life-extender simply because it altered telomere length in a laboratory setting. Even the 2025 TA-65 meta-analysis, which found telomere lengthening, failed to demonstrate a corresponding improvement in functional aging outcomes and pointed to the problem of industry funding for the research. [44]

Commercial proposals for telomerase gene therapy outside of regulated clinical trials should be approached with particular caution. International scientific reviews to date have not confirmed its effectiveness as a treatment for human aging. [45]

Finally, there's no point in trying to "treat" a commercial test result in a healthy person. A short average blood telomere length, on its own, doesn't necessarily indicate a disease.

What's new in recent years?

Over the past few years, the field has become both more promising and more cautious.

On the one hand, new technologies demonstrate that telomerase can indeed be manipulated. In 2025–2026, results were obtained from the temporary delivery of telomerase messenger ribonucleic acid to human lung cells and fibrous tissue, where this was accompanied by telomere lengthening and a reduction in several damage markers. A Spanish telomerase gene therapy program for pulmonary fibrosis is moving through a preclinical toxicology program toward future human trials in 2026. [46]

On the other hand, clinical data remind us that biological logic does not guarantee therapeutic results. A randomized trial of danazol in pulmonary fibrosis with short telomeres was terminated due to lack of the expected effect. [47]

New genetic data also reinforces the notion that maximal elongation is not the goal. A 2026 study of hereditary long telomere syndrome links excessive cellular longevity to a wide range of lymphoid tumors. [48]

This is why the modern research trend is gradually shifting from the slogan "lengthening telomeres" to a more precise question: is it possible to restore normal telomere function in the desired tissue, for a limited time, and without increasing the risk of cancer.

Key points from experts

Elizabeth Blackburn, PhD, is a 2009 Nobel laureate in Physiology or Medicine and Professor Emeritus of Biochemistry and Biophysics at the University of California, San Francisco. She discovered the molecular nature of telomeres and, together with colleagues, the enzyme telomerase. Her laboratory's work laid the foundation for the modern understanding that telomeres are dynamic protective structures, and that telomerase maintains their length. This biology makes telomere lengthening fundamentally possible, but it does not make telomere length a simple indicator of human age or a ready-made target for anti-aging treatments. [49]

Carol Greider, PhD, is a 2009 Nobel laureate in Physiology or Medicine and a distinguished professor of molecular, cellular, and developmental biology at the University of California, Santa Cruz. Her laboratory studies telomere length equilibrium—the dynamic interplay between telomere shortening and telomerase-mediated extension. This approach reflects a contemporary concept: what's biologically significant is not the desire to obtain maximally long telomeres, but the normal regulation of their length. [50]

Mary Armanios is a medical oncologist, professor of oncology, genetic medicine, molecular biology, and genetics at Johns Hopkins University, and director of the Johns Hopkins Telomere Center. Her clinical and scientific work focuses on diseases that arise from both abnormally short and abnormally long telomeres. Her group's research particularly demonstrates the duality of telomere biology: short telomeres cause regenerative failure and fibrotic diseases, while hereditary long telomeres can extend cell lifespan at the cost of increased tumor susceptibility. [51]

Frequently Asked Questions

Is it really possible to make telomeres longer?

Yes, it is biologically possible. Telomerase can extend telomeric DNA, and some human studies have documented an increase in average telomere length. However, a safe telomere-lengthening strategy with proven health benefits in healthy individuals is still lacking. [52]

Does lengthening telomeres mean a person is getting younger?

No. This is a change in a single biomarker. It has not yet been proven that increasing telomere length automatically restores organ function or reduces the biological age of the entire organism.

Is it possible to determine biological age using telomeres?

Only very roughly at the level of population statistics. Individual variability is high, tissues differ, and measurement methods are subject to error. Telomere length alone is considered an insufficient clinical indicator of individual biological age. [53]

Does exercise lengthen telomeres?

Some studies and meta-analyses find a small positive effect, while others do not. The overall evidence for a telomere effect is significantly weaker than the evidence for the overall benefit of physical activity. [54]

Are there any foods that lengthen telomeres?

There is no single product that has been convincingly proven. Healthier dietary patterns are associated with better telomere dynamics, but much of this data is observational. [55]

Can Astragalus Lengthen Telomeres?

There are small human studies available for the standardized derivative TA-65. These studies cannot be automatically generalized to regular astragalus, tinctures, or other herbal supplements.

Should I take TA-65?

It cannot be considered a proven means of rejuvenation or life extension. Studies provide evidence of telomere changes, but have not yet confirmed clinically significant improvements in function or longevity, and long-term cancer safety requires further study. [56]

Can vitamin D lengthen telomeres?

Individual randomized trials provide positive signals, but the overall evidence is mixed. Vitamin D should be taken primarily for generally accepted medical indications, not for artificially lengthening telomeres. [57]

Should I take antioxidants?

There's no evidence that a single antioxidant supplement safely lengthens telomeres and prolongs life. Telomere health depends on many more processes than just oxidative stress.

Can telomeres be lengthened with hormones?

Danazol was able to lengthen telomeres in some patients with rare telomere diseases, but a subsequent randomized trial in pulmonary fibrosis did not confirm benefit. Androgens should not be used for this purpose in healthy individuals. [58]

Is it true that telomerase causes cancer?

Not quite. Telomerase itself doesn't turn a normal cell into a cancer cell, but most malignant cells activate telomerase or another telomere maintenance mechanism to continue dividing. This is why uncontrolled, long-term activation of the enzyme requires caution. [59]

Can stress shorten telomeres?

Studies find a small association between chronic psychological stress and shorter telomere length, but the effect size is small and causality is difficult to establish.[60]

Is it possible to “return” telomeres to the length they were when you were 20?

There is currently no reliable and safe method for the entire human body. Experimental gene and ribonucleic acid technologies are capable of lengthening telomeres in individual cells and tissues, but are in the preclinical or early translational stages. [61]

What should I do if my test shows very short telomeres?

If the test was commercial and the person is healthy, the result alone does not indicate disease. However, if short telomeres are combined with familial pulmonary fibrosis, bone marrow failure, unexplained low blood cell counts, cirrhosis, or other characteristic features, specialized medical and genetic evaluation should be considered. [62]

Main

Telomeres can be lengthened biologically, but medicine hasn't yet proven that deliberately lengthening them is beneficial for healthy individuals. This is the fundamental difference between molecular feasibility and therapeutic benefit.

Physical activity, nutrition, not smoking, and good sleep may be associated with more favorable telomere dynamics. However, these habits should be maintained because they have been proven to improve health, not because there is a guaranteed way to translate them into a certain number of additional telomere base pairs. [63]

Direct activation of telomerase appears more promising scientifically, but requires particular caution. TA-65 alters the telomere biomarker without proven functional benefit, danazol has yielded conflicting results even in telomere-related diseases, and gene and ribonucleic acid therapy are currently primarily being studied for specific severe diseases, not for rejuvenating healthy individuals.

Perhaps the future lies not in general "telomere extension," but in targeted restoration of normal telomere function in specific cells and organs where critical shortening actually causes disease. This goal is much more consistent with modern biology, in which both too-short and excessively long telomeres can have adverse consequences.